We found very low sensitivity of LF-LAM for TB (whether confirmed, or also including clinical diagnoses) among ambulatory outpatients established in HIV care with CD4<200x106/l, which does not support its use for TB screening in this study population. This evidence concerns the gene CD4 and tuberculosis.